|
1BCP
BINARY COMPLEX OF PERTUSSIS TOXIN AND ATP
Deposited 1995-11-21
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
35–269(235 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 2.70 Å
|
|
1BCP
BINARY COMPLEX OF PERTUSSIS TOXIN AND ATP
Deposited 1995-11-21
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain G
35–269(235 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 2.70 Å
|
|
7SKI
Pertussis toxin in complex with PJ34
Deposited 2021-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–214(179 aa)
|
Mutation:C41S
|
P34 N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;295 K;0.15M NaCl, 0.1M Tris(hydroxymethyl)aminomethane pH 8.0, 8% w/v PEG 8000
|
Resolution 1.10 Å
R-free 0.178
|
|
7SKI
Pertussis toxin in complex with PJ34
Deposited 2021-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
36–214(179 aa)
|
Mutation:C41S
|
P34 N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;295 K;0.15M NaCl, 0.1M Tris(hydroxymethyl)aminomethane pH 8.0, 8% w/v PEG 8000
|
Resolution 1.10 Å
R-free 0.178
|
|
7SKK
pertussis toxin in complex with ADPR and Nicotinamide
Deposited 2021-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–216(181 aa)
|
Mutation:C41S
|
NCA NICOTINAMIDE × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.5M (NH4)2SO4 and 0.1M HEPES pH 7
|
Resolution 1.65 Å
R-free 0.198
|
|
7SKK
pertussis toxin in complex with ADPR and Nicotinamide
Deposited 2021-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
36–216(181 aa)
|
Mutation:C41S
|
NCA NICOTINAMIDE × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.5M (NH4)2SO4 and 0.1M HEPES pH 7
|
Resolution 1.65 Å
R-free 0.198
|
|
7SKK
pertussis toxin in complex with ADPR and Nicotinamide
Deposited 2021-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
36–216(181 aa)
|
Mutation:C41S
|
NCA NICOTINAMIDE × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.5M (NH4)2SO4 and 0.1M HEPES pH 7
|
Resolution 1.65 Å
R-free 0.198
|
|
7SKK
pertussis toxin in complex with ADPR and Nicotinamide
Deposited 2021-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
36–216(181 aa)
|
Mutation:C41S
|
NCA NICOTINAMIDE × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.5M (NH4)2SO4 and 0.1M HEPES pH 7
|
Resolution 1.65 Å
R-free 0.198
|
|
7SKY
Pertussis toxin S1 bound to NAD+
Deposited 2021-10-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
36–216(181 aa)
|
Not recorded
|
IOD IODIDE ION × 1
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;25% PEG 3350, 0.2M KI
|
Resolution 1.37 Å
R-free 0.224
|
|
7SKY
Pertussis toxin S1 bound to NAD+
Deposited 2021-10-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–216(181 aa)
|
Not recorded
|
IOD IODIDE ION × 1
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;25% PEG 3350, 0.2M KI
|
Resolution 1.37 Å
R-free 0.224
|
|
7SKY
Pertussis toxin S1 bound to NAD+
Deposited 2021-10-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
36–216(181 aa)
|
Not recorded
|
IOD IODIDE ION × 1
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;25% PEG 3350, 0.2M KI
|
Resolution 1.37 Å
R-free 0.224
|
|
7SKY
Pertussis toxin S1 bound to NAD+
Deposited 2021-10-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
36–216(181 aa)
|
Not recorded
|
IOD IODIDE ION × 1
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;25% PEG 3350, 0.2M KI
|
Resolution 1.37 Å
R-free 0.224
|
|
7SNE
Pertussis toxin S1 subunit bound to BaAD
Deposited 2021-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–216(181 aa)
|
Mutation:C41S
|
9XR [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylanilino)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;0.2M LiCl, 14% w/v PEG 3350
|
Resolution 1.00 Å
R-free 0.219
|
|
7SNE
Pertussis toxin S1 subunit bound to BaAD
Deposited 2021-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
36–216(181 aa)
|
Mutation:C41S
|
9XR [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylanilino)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;0.2M LiCl, 14% w/v PEG 3350
|
Resolution 1.00 Å
R-free 0.219
|
|
7SNE
Pertussis toxin S1 subunit bound to BaAD
Deposited 2021-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
36–216(181 aa)
|
Mutation:C41S
|
9XR [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylanilino)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;0.2M LiCl, 14% w/v PEG 3350
|
Resolution 1.00 Å
R-free 0.219
|
|
7SNE
Pertussis toxin S1 subunit bound to BaAD
Deposited 2021-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
36–216(181 aa)
|
Mutation:C41S
|
9XR [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylanilino)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;0.2M LiCl, 14% w/v PEG 3350
|
Resolution 1.00 Å
R-free 0.219
|
|
7U6Z
Pertussis toxin E129D NAD
Deposited 2022-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
36–216(181 aa)
|
Not recorded
|
IOD IODIDE ION × 1
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;297 K;0.2M KI, 25% PEG3350
|
Resolution 1.30 Å
R-free 0.214
|
|
7U6Z
Pertussis toxin E129D NAD
Deposited 2022-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–216(181 aa)
|
Not recorded
|
IOD IODIDE ION × 1
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;297 K;0.2M KI, 25% PEG3350
|
Resolution 1.30 Å
R-free 0.214
|
|
9MR7
Genetiocally detoxified pertussis toxin in complex with hu1B7 Fab and hu11E6 Fab
Deposited 2025-01-07
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
35–269(235 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.56 Å
|